Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

January 15, 2016January 15, 2016

AbbVie Launches Phase 3 Trials to Evaluate Drug for Rheumatoid Arthritis

News

Illinois-based AbbVie, a global pharmaceutical company, has launched a robust Phase 3 clinical trial program to evaluate the investigational drug ABT-494 in the treatment of rheumatoid arthritis (RA). The program will enroll adults with inadequate ... Read more

January 13, 2016January 13, 2016

Potential Rheumatoid Arthritis Therapy Under FDA Review

News

Regeneron Pharmaceuticals, Inc., and Sanofi announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for sarilumab, an investigational, human monoclonal antibody intended to treat patients with ... Read more

January 11, 2016January 11, 2016

Potential Rheumatoid Arthritis Treatment Phase 3 Trial Protocol Submitted

News

Can-Fite BioPharma Ltd. announced it has submitted its Phase 3 clinical trial protocol to the Institutional Review Board (IRB) of Barzilai Medical Center in Israel, and will also file similar ... Read more

December 9, 2015May 23, 2016

Turmeric To be Evaluated in Rheumatoid Arthritis Clinical Trial

News

Researchers from the University of Arizona dug deeper into the potentials of Turmeric, a native spice from South Asia, for the treatment of Rheumatoid Arthritis (RA). Recognized for centuries in the ... Read more

November 6, 2015November 9, 2015

Novel Inhibitor for Autoimmune Diseases Moving to Phase 2 Trial

News

Hutchison MediPharma Limited (HMP) released the outcome of its Phase I clinical trial of HMPL-523. The first-in-human study was a dose-escalating trial to assess the safety, tolerability, and side effects of single ... Read more